Sigma-Tau Pharmaceuticals, Inc., Consumer Products Division Launches Phototrop dietary supplement for the support of visual function.

Share Article

Sigma-Tau Pharmaceuticals, Inc., Consumer Products Division Launches Phototrop dietary supplement for the support of visual function.

FOR IMMEDIATE PUBLICATION

Gaithersburg, MD Sigma-Tau Pharmaceuticals, Inc. is excited to introduce Phototrop, a patented dietary supplement specifically formulated to help support visual function.

Phototrop is the metabolic approach to supporting visual function:

  • Promotes metabolic activity in the retina*
  • Supports normal* maintenance process of photo receptor cells*
  • Helps reduce oxidative damage to the retina*

Phototrop has been the subject of a double blind, placebo controlled clinical study1

Phototrop is designed for long-term use and should be taken daily for maximum benefit, preferably with food. Simply take two capsules per day with food or as directed by your healthcare provider.

Sigma-Tau Consumer Products is a division of Sigma-Tau Pharmaceuticals, Inc., headquartered in Gaithersburg, MD. and is committed to producing high quality non-prescription medicines and nutritional supplements that help to mitigate the damaging effects of aging, disease and/or medical-surgical treatments.

For information on Phototrop, please contact customer service at 1-800-EYE-HLTH (393-4584) or visit us at http://www.phototrop.com

Contact:    Marc Tewey

        Director

        Sigma-Tau Consumer Products Division

        Phone: 800-447-0169 x 518

        Fax:      301-354-5342

References: J. Feher et al. Improvement of Visual Functions, and Fundus Alterations in Early Age-Related Macular Degeneration Treated with a Combination of Acetyl-L-Carnitine, n-3 Fatty Acids, and Coenzyme Q10 (PHOTOTROP). Ophthalmologica 2005;219:154–166

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

# # #

Share article on social media or email:

View article via:

Pdf Print